To identify which receptor was responsible for HMGB1 binding, we pretreated live DU145 tumor cells with anti-TLR4, anti-RAGE or the combination of both antibodies for 30 min prior to addition of recombinant HMGB1 (Fig. 2C). This evidence concerns the gene TLR4 and neoplasm.